MAYA
Inflection Point Acquisition Corp. V10.31
+0.00+0%
Nov 24, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
122.79MP/E (TTM)
-Basic EPS (TTM)
-Dividend Yield
0%Recent Filings
10-K
FY2025 results
Inflection Point Acquisition Corp. V, a blank check company, reported no revenue for FY2025 ended December 31, 2025, with $89.3M held in trust from its February 2025 IPO of 8.6M units at $10 each. Net income reached $397K, driven by $3.1M interest on trust assets, while operating costs hit $2.7M amid sponsor changes and GOWell merger pursuit. No Q4 metrics disclosed; cash outside trust dwindled to $26K with a $2.1M working capital deficit. Sponsors hold 27.6% voting power. Heavy redemptions could derail the deal.
8-K
Board adds Trabuco pre-merger
Inflection Point Acquisition Corp. V expanded its board from four to five directors on January 20, 2026, appointing Carolyn Trabuco as a Class II director through the second annual shareholder meeting and audit committee member. She receives 20,000 of 4,481,250 restricted GOWell Energy Technology shares tied to the pending business combination with GOWell Technology Limited. No other material arrangements. Board bolsters ahead of deal close.
8-K
Sponsor note amended to $700K
Inflection Point Acquisition Corp. V amended its promissory note with sponsor Inflection Point Fund I LP on January 7, 2026, boosting the principal to $700,000 after a $200,000 working capital advance. The original $500,000 repays only on business combination closing; the new tranche earlier if liquidated. Funds bridge to the pending GOWell merger. No prepayment allowed.
8-K
SPAC amends de-SPAC warrant terms
Inflection Point Acquisition Corp. V amended its October 13, 2025 Business Combination Agreement with GOWell Technology Limited on December 22, 2025, clarifying the number of PubCo Series A Investor Warrants issued upon conversion of Company Warrants at the second merger effective time. No other terms changed. Proxy statement/prospectus forthcoming.
8-K
Name change effective
BAYA
Bayview Acquisition Corp
11.63-0.01
CAPN
Cayson Acquisition Corp
10.61-0.01
DMAA
Drugs Made In America Acquisiti
10.36-0.00
MBAV
M3-Brigade Acquisition V Corp.
10.80-0.01
QETA
Quetta Acquisition Corporation
11.20-0.05
SDHI
Siddhi Acquisition Corp
10.25+0.00
SIMA
SIM Acquisition Corp. I
10.57+0.01
SOUL
Soulpower Acquisition Corporati
10.13+0.00
UYSC
UY Scuti Acquisition Corp.
10.22+0.00
YOTA
Yotta Acquisition Corporation
2.00+0.00